<

 
Data updated 2025-05-09 00:05:01
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date18730908.3 (espacenet)  (Federated)  (European Patent Register), 20180524
Patent/reg. no. and dateDK/EP 3630164, 20230823
Publication date20200408
Priority no. and dateUS 201762513556 P, 20170601
EP pub. no. and date EP 3630164 20200408
Effective date
Applicant/ownerEli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US
Applicant ref. no.V463159DK00
InventorBOTROS, Fady Talaat, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
LAKSHMANAN, Mark Chandrakant, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
TUTTLE, Katherine Rose, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
ZIMMERMANN, Alan George, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US
RepresentativeZacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S
Opponent
IPC ClassA61K 38/26 (2006.01) , A61K 38/28 (2006.01) , A61K 45/06 (2006.01) , A61P 13/12 (2006.01) , G01N 33/68 (2006.01) 
TitleDulaglutid til behandling af kronisk nyresygdom
Int. application no.US2018034278
Int. publication no.WO2018222472
Related patent (certificate)
StatusRettet DK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact